Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2007; 12: 302–3
The Natural Standard Research Collaboration has partnered with the World Health Organization (WHO) to author Assessment of the Risk of Hepatotoxicity with Kava Products, a publication that explores the controversial threat of liver damage as a result of products containing Piper methysticum (kava). The report includes a description of P. methysticum and its various preparations and historical uses, as well as interactions and side-effects. It provides the details of an investigation into P. methysticum’s possible association with hepatic toxicity, or chemically-induced liver damage. In addition it contains safety information as determined by several clinical trials and a case by case analysis of patients who experienced liver damage while using P. methysticum products. The report also provides regulatory information, analytical results and clinical recommendations specific to this issue.
<http://www.medicalnewstoday.com/articles/78549.php>, accessed September 24, 2007.